Characterization of mab aggregation using a Cary 60 UV-Vis Spectrophotometer and the Agilent 1260 Infinity LC system

Similar documents
Separate and Quantify Rituximab Aggregates and Fragments with High-Resolution SEC

Application Note. Authors. Abstract. Biopharmaceuticals

A Comprehensive Workflow to Optimize and Execute Protein Aggregate Studies

Charge Heterogeneity Analysis of Rituximab Innovator and Biosimilar mabs

High-throughput and Sensitive Size Exclusion Chromatography (SEC) of Biologics Using Agilent AdvanceBio SEC Columns

Disulfide Linkage Analysis of IgG1 using an Agilent 1260 Infinity Bio inert LC System with an Agilent ZORBAX RRHD Diphenyl sub 2 µm Column

Clone Selection Using the Agilent 1290 Infinity Online 2D-LC/MS Solution

High-resolution Analysis of Charge Heterogeneity in Monoclonal Antibodies Using ph-gradient Cation Exchange Chromatography

Seamless Method Transfer from an Agilent 1260 Infinity Bio-inert LC to an Agilent 1260 Infinity II Bio-inert LC

Application Note. Author. Abstract. Biopharmaceuticals. Verified for Agilent 1260 Infinity II LC Bio-inert System. Sonja Schneider

Reducing Cycle Time for Charge Variant Analysis of Monoclonal Antibodies

Molecular Characterization of Biotherapeutics The Agilent 1260 Infi nity Multi-Detector Bio-SEC Solution with Advanced Light Scattering Detection

Size Exclusion Chromatography of Biosimilar and Innovator Insulin Using the Agilent AdvanceBio SEC column

Agilent AdvanceBio SEC Columns for Aggregate Analysis: Instrument Compatibility

Peptide Mapping: A Quality by Design (QbD) Approach

AdvanceBio HIC: a Hydrophobic HPLC Column for Monoclonal Antibody (mab) Variant Analysis

Multiple Detector Approaches to Protein Aggregation by SEC

Lifetime stability of size exclusion chromatography columns for protein aggregate analysis

Fraction Analysis of Cysteine Linked Antibody-Drug Conjugates Using Hydrophobic Interaction. chromatography. Agilent 1260 Infinity II Bio-Inert System

Analysis of Intact and C-terminal Digested IgG1 on an Agilent Bio MAb 5 µm Column

Method Transfer from an Agilent 1200 Series LC to an Agilent 1260 Infinity II LC

Mobile Phase Optimization in SEC Method Development

Application of Agilent AdvanceBio Desalting-RP Cartridges for LC/MS Analysis of mabs A One- and Two-dimensional LC/MS Study

HIC as a Complementary, Confirmatory Tool to SEC for the Analysis of mab Aggregates

Agilent 1290 Infinity Binary LC System with ISET Emulation of a Waters Alliance 2695 LC Applying Concave, Convex, and Linear Gradients

Protein Separation with ph Gradients Using Composite Buffer Systems Calculated by the Agilent Buffer Advisor Software

Performance characteristics of the 1260 Infinity Quaternary LC system

Separation of Recombinant Human Erythropoietin (repo) Using Agilent Bio SEC-3

Emulation of the Agilent 1100 Series LC Through Waters Empower Software Analysis of an Analgesic Mixture

Seamless Method Transfer between the Agilent Cary 8454 UV- Visible Spectrophotometer and the 8453 UV-Visible Spectrophotometer

Understanding the Effects of Common Mobile Phase Additives on the Performance of Size Exclusion Chromatography

Fast and High Resolution Analysis of Intact and Reduced Therapeutic Monoclonal Antibodies (mabs)

A universal chromatography method for aggregate analysis of monoclonal antibodies

Characterize mab Charge Variants by Cation-Exchange Chromatography

Application Note. Author. Abstract. Pharmaceuticals. Detlef Wilhelm ANATOX GmbH & Co. KG. Fuerstenwalde, Germany mau

Application Note. Abstract. Author. Biopharmaceutical

Agilent 1290 Infinity Binary LC System with ISET - Emulation of the Waters Alliance 2695 LC system analyzing b-blockers

Optimizing Protein Separations with Agilent Weak Cation-Exchange Columns

Scale-up with the Agilent SD-1 Purification System analytical and preparative runs on a single system

Application Note. Author. Abstract. Biotherapeutics and Biologics. Sonja Schneider Agilent Technologies, Inc. Waldbronn, Germany

Spectroscopy Solutions for Pharmaceuticals:

Application Note. Author. Abstract. Pharmaceuticals. A.G.Huesgen Agilent Technologies, Inc. Waldbronn, Germany

Characterization of IgG monomers & their aggregates

Determination of Asarinin in Xixin (Asari Radix Et Rhizoma)

Application Note. Author. Abstract. Small Molecule Pharmaceuticals & Generics. A.G.Huesgen Agilent Technologies, Inc. Waldbronn, Germany

mab Titer Analysis with the Agilent Bio-Monolith Protein A Column

Choosing the Right Calibration for the Agilent Bio SEC-3 Column

ph gradient analysis of IgG1 therapeutic monoclonal antibodies using a 5 µm WCX column

Fast Analysis of Environmental Phenols with Agilent Poroshell 120 EC-C18 Columns

Cell Clone Selection Using the Agilent Bio-Monolith Protein A Column and LC/MS

High-Resolution Separation of Intact Monoclonal Antibody Isoforms

Impurity Detection with a New Light Emitting Diode Induced Fluorescence Detector Coupled to the Agilent 7100 Capillary Electrophoresis System

Size Exclusion BioHPLC Columns

Application Note. Author. Abstract. Small Molecule Pharmaceuticals. Sonja Krieger Agilent Technologies, Inc. Waldbronn, Germany

Rapid UHPLC Analysis of Reduced Monoclonal Antibodies using an Agilent ZORBAX Rapid Resolution High Definition (RRHD) 300SB-C8 Column

Method Transfer from an Agilent 1260 Infinity LC to an Agilent 1260 Infinity II LC

Agilent 1260 Infinity Bio-inert Quaternary LC System. Infinitely better for bio-molecule analysis

High-Throughput LC/MS Purification of Pharmaceutical Impurities

Characterize Fab and Fc Fragments by Cation-Exchange Chromatography

GOOD LABORATORY PRACTICE Agilent Cary 8454 UV-Visible Spectroscopy System

Automated Scouting of Stationary and Mobile Phases Using the Agilent 1290 Infinity II Method Development Solution

Cell Culture Optimization Using an Agilent Bio-Monolith Protein A Column and LC/MS

Technical Overview. Author. Abstract. A.G.Huesgen Agilent Technologies, Inc. Waldbronn, Germany

Agilent 1290 Infinity LC with ISET under Waters Empower control Emulation of Agilent 1100 Series LC

Application Note. Environmental. Agilent 1290 Infinity Binary LC. with ISET and fine-tuning. Agilent 1290 Infinity Binary LC.

Agilent 1290 Infinity II 2D-LC Solution Biopharmaceutical Polymer Analysis. WCBP Jan 2017 Washington, DC

Agilent OpenLAB CDS MatchCompare for the Comparison of Peptide Mapping Samples

Using a Diode Array UV-Vis in Regulated Environments

Comparing gradient transfer of isocratic hold and delay volume addition using the Agilent 1290 Infinity LC with ISET

Precise Characterization of Intact Monoclonal Antibodies by the Agilent 6545XT AdvanceBio LC/Q-TOF

Quality-by-Design-Based Method Development Using an Agilent 1290 Infinity II LC

Higher Order mab Aggregate Analysis using New Innovative SEC Technology

Application Note. Biopharma. Authors. Abstract. James Martosella, Phu Duong Agilent Technologies, Inc Centreville Rd Wilmington, DE 19808

Developing Purification Strategies for the Agilent 1260 Infinity II Preparative LC/MSD System

As reported before, the employed dose was 10 mg/ml is in according with commonly used dose.

Agilent 1290 Infinity Quaternary LC Support of Columns with 2.1 to 4.6 mm ID to 1200 bar

Performance Characteristics of the Agilent 1220 Infinity Gradient LC system

Improved Sensitivity with the Agilent 1290 Infinity Evaporative Light Scattering Detector (ELSD)

Reversed-phase Separation of Intact Monoclonal Antibodies Using Agilent ZORBAX Rapid Resolution High Definition 300SB-C8 1.

Technical Overview. Author. Abstract. Edgar Naegele Agilent Technologies, Inc. Waldbronn, Germany

Automated QbD-Based Method Development and Validation of Oxidative Degraded Atorvastatin

High-Resolution Charge Variant Analysis for Top-Selling Monoclonal Antibody Therapeutics Using a Linear ph Gradient Separation Platform

Final Report. Characterisation of Sample Report. Job No 2016/11/12-34 AS No. 1234A. Client Example Contact Sample. Signed. Example report.

Supplementary Information

Validation of a Dual Wavelength Size Exclusion HPLC Method with Improved Sensitivity to Detect Aggregates of a Monoclonal Antibody Biotherapeutic

Analysis of Monoclonal Antibody (mab) Using Agilent 1290 Infinity LC System Coupled to Agilent 6530 Accurate-Mass Quadrupole Time-of-Flight (Q-TOF)

Experiment 11. DNA Composition by HPLC 1,2

The Agilent 1260 Infinity BioInert Quaternary Pump. Scope of a low-pressure mixing UHPLC pump with Bio-Inert Capabilities

APPLICATION NOTE. Application Note. Summary/Abstract:

ADVANCE ACCURACY AND PRODUCTIVITY FOR FASTER ANALYSIS

Fast and Efficient Peptide Mapping of a Monoclonal Antibody (mab): UHPLC Performance with Superficially Porous Particles

ADVANCE ACCURACY AND PRODUCTIVITY FOR FASTER ANALYSIS

Bio-Monolith Protein G Column - More Options for mab Titer Determination

Faster Separations Using Agilent Weak Cation Exchange Columns

Application Note. Authors. Abstract. Introduction. Pharmaceutical

Fast Method Development Using the Agilent 1290 Infinity Quaternary LC System with Column Selection Valve

ProSEC 300S. Protein Characterization columns

Benefits of 2D-LC/MS/MS in Pharmaceutical Bioanalytics

Size exclusion chromatography for Biomolecule analysis: A "How to" Guide

Columns for Biomolecules BioLC Column Lines

Transcription:

Characterization of mab aggregation using a Cary 60 UV-Vis Spectrophotometer and the Agilent 1260 Infinity LC system Application Note Biopharmaceuticals Authors Arunkumar Padmanaban and Sreelakshmy Menon Agilent Technologies, Inc. Bangalore, India Introduction Monoclonal antibodies (mabs) are important bioproducts, widely manufactured by pharmaceutical companies. With the increased use of mabs in biological processes, techniques that allow them to be characterized in detail are of great interest to pharma companies. Protein aggregates are a topic of intense discussions between regulatory authorities, academics, and manufacturers due to their impact on biological activity [1]. Sub-visible protein aggregates may expose epitopes that may not be present when the protein is in a stable form. Reliably identifying the presence of aggregates is of critical importance in characterization of mabs.

The formation of aggregates is influenced by numerous factors during manufacturing, purification, formulation, and storage. A quick QC method to identify, the presence of protein aggregation is therefore advantageous. It could be used at many stages of the life cycle of antibody manufacturing (such as in clonal screening), as well as for continuous product monitoring during storage. The advantage of UV spectroscopy as an analytical method to detect protein aggregation is that it is non-destructive. It also uses low sample volumes, minimal sample preparation requirement and easy sample analysis. A quick QC method to indicate the presence of aggregation is presented in this study. The method uses an Agilent Cary 60 UV-Vis spectrophotometer to identify aggregation of mab solutions resulting from different stress conditions. The presence of aggregation was confirmed by size exclusion chromatography (SEC) analysis, the standard method used to characterize protein aggregation. Experimental Reagents and samples: Commercially available mab was purchased from a local pharmacy and stored according to the manufacturers instructions. Both monobasic and dibasic sodium hydrogen phosphate were purchased from Sigma-Aldrich. The buffers were prepared fresh and then filtered using a 0.22 µm membrane before use. Sample preparations: The mab samples were subject to two different stress methods to induce aggregation: thermal stress; and accelerated freeze-thaw stress (see following). The untreated (unstressed) sample was used as a control for analytical measurements. Thermal stress The mab samples were diluted in water to 1 mg/ml concentration. 100 µl aliquots of diluted mab sample were contained in 0.5 ml Eppendorf tubes. They were then thermally stressed by incubation at 65 C for 5 and 10 minutes using the ThermoMixer (Eppendorf). The samples were allowed to cool down to room temperature before analytical measurements. Accelerated freeze-thaw stress: Single 100 µl aliquots of 1 mg/ml mab sample were placed in 0.5 ml Eppendorf tubes. These tubes were immersed in an ethanol-dry ice bath until the solution froze. The frozen samples were then immediately placed in the thermomixer for 4 minutes at 30 C. Once the samples had thawed completely, they were flash-frozen again. This freeze-thaw cycle was repeated 15 times before analytical characterization. 2 UV spectral scan: Spectral scans of the control and stressed mab samples were performed using an Agilent Cary 60 UV-Vis Spectrophotometer. A 50 µl aliquot of the sample was placed in an Agilent sub-micro rectangular quartz cuvette (10 mm pathlength). The sample absorbance was recorded against a blank-corrected baseline from 240 to 380 nm. The aggregation index (A.I.) was calculated using the equation [2] shown in Figure 1. The data acquisition and analysis was carried out using the Agilent Cary WinUV Scan Application. Figure 1. Aggregation Index calculation Where OD 350 represents the absorbance (%Abs) at 350 nm and OD280-OD350 is difference in the absorbance at 280 and 350 nm respectively. Size exclusion chromatography (SEC): SEC analysis of the samples was carried out using an Agilent 1260 Infinity bio-inert LC system comprising: Agilent 1260 Infinity Bio-inert Quaternary LC pump Agilent 1260 Infinity High-performance Bio-inert Autosampler Agilent 1260 Infinity Thermostat with bio-inert heat exchangers Agilent Thermostatted Column Compartment Agilent 1260 Infinity Diode Array Detector VL Plus Agilent AdvanceBio SEC 300 Å, 7.8 300 mm, 2.7 μm LC column LC parameters are presented in Table 1. These parameters were adopted from a different study [3] and were re-used for the separation. The peak areas of the monomer and aggregate were calculated and compared with the control samples. OpenLAB CDS ChemStation was used for data acquisition and analysis.

Table 1. LC instrument conditions. Parameter Setting Mobile Phase A 150 mm sodium phosphate ph 7.0 Column TCC Temperature 25 C Isocratic run Run time AdvanceBio SEC 2.7 μm 300 Å 7.8 300 mm column Mobile phase A 15 mins Injection volume 5 µl Flow rate DAD Results and Discussion 0.8 ml/min 220 and 280 nm UV spectroscopy UV absorbance spectroscopy offers the simplest, nondestructive way of making quantitative measurements of a protein solution. The method can be used to quantify proteins without the need for a chemical derivatization or complex dye coupling reactions. The mab samples that had been subjected to different conditions to induce aggregate formation were measured using the Cary 60 UV-Vis spectrophotometer. The Cary 60 is suited for measuring biosamples because the xenon flash lamp source does not photodegrade light-sensitive samples. Agilent offers a wide selection of quartz cuvettes, with sample volumes ranging from 5 µl to 1 ml. A sub-micro quartz cuvette with a sample volume of 50 µl and a path length of 10 mm was used in this study. Using this cuvette ensured that sample loss was minimized and measurements were able to be taken with low sample volumes. Any absorbance signal above 320 nm is attributed to the scattering of the light by aggregate particles. Aggregate-free protein solutions do not have absorption above 320 nm [4]. The spectral scans of the non-stressed and stressed mab samples are presented in Figure 2. Panel A shows the absorbance spectrum of thermally stressed samples. A slight increase in the optical density at 350 nm can be observed. This spectrum contrasts with that of the freeze-thaw stressed sample in panel B, which shows a significant increase in the optical density at 350 nm. A log-log plot of the same data is presented as insets in each of the panels on Figure 2. They show the contribution of scattering to the overall absorbance. The change in the optical density of the solution can be clearly seen in the increasing shift of the UV traces. The aggregation index (AI) was calculated from these data using the equation in Figure 1, and the change in aggregation index is presented in Table 2. The samples that had been subject to repeated freeze-thaw cycles show a higher aggregation index than both the control samples and those subjected to thermal stress. From these data, it can be observed that freeze-thaw stress leads to a greater formation of aggregates than thermal stress. This could be due to factors such as partial unfolding at the ice-liquid interface, ph changes as buffer salt crystallizes, and solute concentration during ice crystal growth. Figure 2.UV absorption spectra of non-stressed mab and stressed mab samples. Panel A: thermal stress samples and Panel B: Freeze-thaw stressed samples. Inset shows the log-log plot Table 2. Aggregation index change in non-stressed and stressed samples with different conditions. Sample OD 280 nm OD 350 nm Aggregation Index Non-Stressed IgG 1.57 0.01 0.5 65 C 5 min 1.69 0.02 1.1 65 C 10 min 1.72 0.04 2.5 15 x Freeze thaw (FT) 1.82 0.10 5.8 SEC analysis: All samples were analyzed using the Agilent AdvanceBio SEC column with 2.7 µm particle size. The AdvanceBio SEC column efficiently separated the monomer peak, aggregate peaks, and also the small molecule preservatives contained in the formulation. High resolution of the monomer and the aggregate peaks were achieved within a short analysis time. The SEC chromatogram for thermally stressed samples is presented in Figure 3 panel A and freeze-thaw samples in panel B. All samples showed a major monomer peak occupying about 99 % in total peak area. A small amount of aggregate peak was found to be present at 7 minutes in control samples. The chromatogram of the thermally stressed samples shows an appearance of the additional 3

peak at retention time of 6 minutes. This peak is absent in control samples. Also, the treated samples show an increase in baseline around 11 minutes indicating degraded mab. The chromatogram shows that on thermal treatment, some of the intrinsic aggregate has changed into higher-order aggregate species. Although the overall aggregate peak area is same, the different forms of aggregate can be separated using the SEC analysis. The overlaid chromatogram of the control sample and 15X freeze-thawed samples is shown in panel B. This shows an increase in peak area of the aggregate at 7 minutes in stressed samples. The peak area percentage of the monomer and aggregate peaks presented in Table 3 show high aggregation on repeated freeze-thaw cycles compared to thermal degradation. The UV spectra showed a similar result. Table 3. Peak Area % of the aggregate and monomer peak from SEC chromatogram of different conditions. Conclusions The results of this study suggest that an Agilent Cary 60 UV-Vis spectrophotometer can be used to monitor the presence of aggregate in monoclonal antibody solutions. While the method cannot separate different forms of aggregate, it can be used as a quick screening method to identify the presence of aggregates, before using SEC analysis to separate them. The Agilent AdvanceBio SEC column, used with the Agilent 1260 Bio-LC system, proved capable of delivering high resolution analysis of mab aggregates within a short run times mab sample Aggregate Peak Area % Monomer Non-Stressed mab 0.73 99.13 65 C 5 min 0.68 99.23 65 C 10 min 0.67 99.20 15 x Freeze thaw (FT) 1.18 98.65 The UV absorbance data and the SEC data correlate well in assessing the presence of aggregate. Although UVabsorbance method cannot separate the aggregates, it can be used as a quick tool before the SEC characterization. The UV absorbance method offers advantages of low sample volume, reusable sample, and easy instrument set up and less than a minute reading. Figure 2. SEC chromatogram overlay of non-stressed and stressed mab samples. Panel A: thermally stressed samples showing the formation of aggregate peaks. Panel B freeze-thaw samples showing an increase in the aggregate peak 4

References 1. Vázquez-Rey, et al. Aggregates in monoclonal antibody manufacturing processes. Biotechnol. Bioeng. 2011, 108. 2. Hawe, A, et al. Structural properties of monoclonal antibody aggregates induced by freeze-thawing and thermal stress. Eur J Pharm Sci. 2009, 38. 3. Coffey, A. et al. A comprehensive workflow to optimize and execute protein aggregate studies. Agilent Technologies application note. Publication no 5991-7476EN. 2017. 4. Raynal, B. et al. Quality Assessment and Optimization of Purified Protein Samples: Why and How? Microb Cell Fact. 2014, 13. www.agilent.com/chem For Research Use Only. Not for use in diagnostic procedures. This information is subject to change without notice. Agilent Technologies, Inc. 2017 Published April 9, 2017 Publication number: 5991-7974EN